EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Abcb4-defect cholangitis mouse model with hydrophobic bile acid composition by in vivo liver-specific gene deletion

Kota Tsuruya, Keiko Yokoyama, Yusuke Mishima, Kinuyo Ida, Takuma Araki, Satsuki Ieda, Masato Ohtsuka, Yutaka Inagaki, Akira Honda, Tatehiro Kagawa, Akihide Kamiya

Journal of Lipid Research · 2024

DOI: 10.1016/j.jlr.2024.100616 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Lipid Research, 2024. Verfasst von Kota Tsuruya und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan; Department of Molecular…. Hauptthemen laut MEDLINE: ATP Binding Cassette Transporter, Subfamily B, Bile Acids and Salts, Liver. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Progressive familial intrahepatic cholestasis (PFIC) is a liver disease that occurs during childhood and requires liver transplantation. ABCB4 is localized along the canalicular membranes of hepatocytes, transports phosphatidylcholine into bile, and its mutation causes PFIC3. Abcb4 gene-deficient mice established as animal models of PFIC3 exhibit cholestasis-induced liver injury. However, their phenotypes are often milder than those of human PFIC3, partly because of the existence of large amounts of less toxic hydrophilic bile acids synthesized by the rodent-specific enzymes Cyp2c70 and Cyp2a12. Mice with double deletions of Cyp2c70/Cyp2a12 (CYPDKO mice) have a human-like hydrophobic bile acid composition. PFIC-related gene mutations were induced in CYPDKO mice to determine whether these triple-gene-deficient mice are a better model for PFIC. To establish a PFIC3 mouse model using CYPDKO mice, we induced abcb4 gene deletion in vivo using adeno-associated viruses expressing SaCas9 under the control of a liver-specific promoter and abcb4-target gRNAs. Compared to Abcb4-deficient wild-type mice, Abcb4-deficient CYPDKO mice showed more pronounced liver injury along with an elevation of inflammatory and fibrotic markers. The proliferation of intrahepatic bile ductal cells and hematopoietic cell infiltration were also observed. CYPDKO/abcb4-deficient mice show a predominance of taurine-conjugated chenodeoxycholic acid and lithocholic acid in the liver. In addition, phospholipid levels in the gallbladder bile were barely detectable. Mice with both human-like bile acid composition and Abcb4-defect exhibit severe cholestatic liver injury and are useful for studying human cholestatic diseases and developing new treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ATP Binding Cassette Transporter, Subfamily BBile Acids and SaltsLiverAnimalsHumansMaleMiceATP-Binding Cassette Sub-Family B Member 4Cholestasis, IntrahepaticCytochrome P-450 Enzyme SystemDisease Models, AnimalGene DeletionHydrophobic and Hydrophilic InteractionsMice, Knockout

Stichwörter der Autor:innen

adeno-associated virusbile acid compositiongenome editingprogressive familial intrahepatic cholestasis

Substanzen

ATP Binding Cassette Transporter, Subfamily BATP-Binding Cassette Sub-Family B Member 4Bile Acids and Saltscytochrome P-450 2C70, mouseCytochrome P-450 Enzyme Systemmultidrug resistance protein 3

Autor:innen und Institutionen

  • Division of Gastroenterology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan; Department of Molecular Life Sciences, Tokai University School of Medicine, Isehara, Kanagawa…
  • Department of Molecular Life Sciences, Tokai University School of Medicine, Isehara, Kanagawa, Japan; Support Center of Medical Research and Education, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
  • Department of Molecular Life Sciences, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
  • Division of Gastroenterology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
  • Center for Matrix Biology and Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
  • Joint Research Center, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan; Department of Gastroenterology and Hepatology, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan.

Zitieren

APA

Tsuruya, K., Yokoyama, K., Mishima, Y., Ida, K., Araki, T., Ieda, S., Ohtsuka, M., Inagaki, Y., Honda, A., Kagawa, T., & Kamiya, A. (2024). Abcb4-defect cholangitis mouse model with hydrophobic bile acid composition by in vivo liver-specific gene deletion. Journal of Lipid Research. https://doi.org/10.1016/j.jlr.2024.100616

Vancouver

Tsuruya K, Yokoyama K, Mishima Y, Ida K, Araki T, Ieda S, et al. Abcb4-defect cholangitis mouse model with hydrophobic bile acid composition by in vivo liver-specific gene deletion. Journal of Lipid Research. 2024. doi:10.1016/j.jlr.2024.100616

BibTeX
@article{Tsuruya2024,
  author = {Tsuruya, Kota and Yokoyama, Keiko and Mishima, Yusuke and Ida, Kinuyo and Araki, Takuma and Ieda, Satsuki and Ohtsuka, Masato and Inagaki, Yutaka and Honda, Akira and Kagawa, Tatehiro and Kamiya, Akihide},
  title = {Abcb4-defect cholangitis mouse model with hydrophobic bile acid composition by in vivo liver-specific gene deletion},
  journal = {Journal of Lipid Research},
  year = {2024},
  doi = {10.1016/j.jlr.2024.100616}
}
Kostenlos starten →